P1531: TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON-HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE

相似书籍

• P1544: IMPACT OF SARS-COV 2 INFECTION, IN TREATED NHL-B AND HD, AFTER VACCINATION AND PREVENTIVE THERAPY WITH ANTIBODIES: OUR EXPERIENCE
  由: Luca Pezzullo, et al.
  出版: (2023-08-01)
• A rare immune-related mesenteric and retroperitoneal serositis in a multirefractory Hodgkin lymphoma patient successfully treated with chylolymphostatic surgery
  由: Matteo D'Addona, et al.
  出版: (2023-10-01)
• Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma
  由: Valentina Giudice, et al.
  出版: (2022-04-01)
• Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study
  由: Danilo De Novellis, et al.
  出版: (2022-07-01)
• Peripheral T Cell Non-Hodgkin’s Lymphoma following Treatment of Hodgkin’s Lymphoma
  由: Sun Hee Chang, et al.
  出版: (2015-01-01)